Brand Name | Status | Last Update |
---|---|---|
bicillin c-r 900/300 | New Drug Application | 2023-10-13 |
bicillin cr | New Drug Application | 2023-10-13 |
bicillin l-a | New Drug Application | 2024-01-17 |
buffered penicillin g potassium | ANDA | 2020-02-22 |
extencilline | unapproved drug for use in drug shortage | 2023-12-13 |
penicillin g potassium | ANDA | 2022-10-24 |
penicillin g sodium | ANDA | 2020-05-27 |
pfizerpen | ANDA | 2023-12-15 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Syphilis | D013587 | EFO_0007504 | A53.9 | 1 | 3 | 4 | 5 | 1 | 13 |
Infections | D007239 | EFO_0000544 | — | — | — | 3 | 4 | 1 | 8 |
Pneumonia | D011014 | EFO_0003106 | — | — | 1 | 3 | 1 | 2 | 6 |
Sepsis | D018805 | HP_0100806 | A41.9 | — | — | 2 | 1 | 1 | 4 |
Yaws | D015001 | EFO_0007548 | A66 | — | — | 2 | 1 | — | 3 |
Bacteremia | D016470 | EFO_0003033 | R78.81 | — | 1 | — | 2 | — | 3 |
Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | — | — | 2 | — | 2 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | — | — | 1 | — | 1 |
Nephrolithiasis | D053040 | — | N20.0 | — | — | — | 1 | — | 1 |
Neutropenia | D009503 | — | D70 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neurosyphilis | D009494 | EFO_0007339 | A50.4 | — | — | 1 | — | 2 | 3 |
Bacterial infections | D001424 | — | A49 | — | — | 1 | — | 1 | 2 |
Neonatal sepsis | D000071074 | HP_0040187 | — | — | — | 1 | — | 1 | 2 |
Treponemal infections | D014211 | EFO_1001217 | — | — | — | 1 | — | — | 1 |
Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | 1 | 1 | — | — | 1 |
Cytomegalovirus infections | D003586 | EFO_0001062 | B25 | — | 1 | 1 | — | — | 1 |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | — | 1 | — | — | 1 |
Microbial drug resistance | D004352 | — | — | — | — | 1 | — | — | 1 |
Endocarditis | D004696 | HP_0100584 | — | — | — | 1 | — | — | 1 |
Skin diseases | D012871 | — | L00-L99 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Rheumatic heart disease | D012214 | EFO_1001161 | I09.9 | — | 2 | — | — | 2 | 4 |
Psoriasis | D011565 | EFO_0000676 | L40 | — | 1 | — | — | 1 | 2 |
Covid-19 | D000086382 | — | U07.1 | — | 1 | — | — | — | 1 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Osteomyelitis | D010019 | EFO_0003102 | M86 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Respiratory tract infections | D012141 | — | J06.9 | — | — | — | — | 1 | 1 |
Drug monitoring | D016903 | — | — | — | — | — | — | 1 | 1 |
Pharmacokinetics | D010599 | — | — | — | — | — | — | 1 | 1 |
Hiv infections | D015658 | EFO_0000764 | B20 | — | — | — | — | 1 | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | — | — | 1 | 1 |
Stress urinary incontinence | D014550 | HP_0010992 | — | — | — | — | — | 1 | 1 |
Hepatitis c | D006526 | — | B19.2 | — | — | — | — | 1 | 1 |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | — | — | — | 1 | 1 |
Psoriatic arthritis | D015535 | EFO_0003778 | L40.5 | — | — | — | — | 1 | 1 |
Ulcerative colitis | D003093 | EFO_0000729 | K51 | — | — | — | — | 1 | 1 |
Drug common name | Benzylpenicillin |
INN | benzylpenicillin |
Description | Benzylpenicillin is a penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group. It has a role as an antibacterial drug, an epitope and a drug allergen. It is a penicillin allergen and a penicillin. It is a conjugate acid of a benzylpenicillin(1-). |
Classification | Small molecule |
Drug class | penicillins |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O |
PDB | — |
CAS-ID | 61-33-6 |
RxCUI | — |
ChEMBL ID | CHEMBL29 |
ChEBI ID | 18208 |
PubChem CID | 5904 |
DrugBank | DB01053 |
UNII ID | Q42T66VG0C (ChemIDplus, GSRS) |